Rejuvel Bio-Sciences, Inc.
NUUU
$0.00
$0.000.00%
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | -1.05M | -549.30K | 1.79M | -352.90K | -734.80K |
| Total Depreciation and Amortization | 8.60K | 8.10K | 7.40K | 6.60K | 5.10K |
| Total Amortization of Deferred Charges | 228.20K | 114.50K | 18.90K | 75.90K | 43.10K |
| Total Other Non-Cash Items | -24.50K | -362.30K | -2.46M | -433.10K | 69.80K |
| Change in Net Operating Assets | 215.90K | 100.80K | 98.00K | 209.50K | 150.70K |
| Cash from Operations | -623.50K | -688.00K | -543.80K | -493.70K | -465.80K |
| Capital Expenditure | 0.00 | -16.50K | -18.30K | -18.30K | -28.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.00K | -15.00K | -15.00K | -15.00K | -- |
| Cash from Investing | -15.00K | -31.50K | -33.30K | -33.30K | -28.30K |
| Total Debt Issued | 479.30K | 462.30K | 243.50K | 148.50K | 148.50K |
| Total Debt Repaid | -118.30K | -69.70K | -108.90K | -119.70K | -134.80K |
| Issuance of Common Stock | 94.80K | 317.50K | 389.00K | 538.20K | 538.20K |
| Repurchase of Common Stock | -8.70K | -9.70K | -9.70K | -9.70K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.50K | -130.60K | -110.70K | 4.50K | 126.70K |
| Cash from Financing | 451.60K | 569.80K | 403.20K | 561.80K | 677.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -187.00K | -149.90K | -174.20K | 34.50K | 183.20K |
